Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH-797804 add-on to tiotropium in adults with moderate to severe COPD
2011-005864-11Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2012
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing PH-797804 plus tiotropium bromide with Placebo plus tiotropium bromide (2 arms). Primary endpoint: Change from baseline in trough FEV1 at Week 12. Started Apr 2012; status: completed.
02
Drugs
PH-797804
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2011-005864-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005864-11.